1. Home
  2. ATYR vs KRT Comparison

ATYR vs KRT Comparison

Compare ATYR & KRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • KRT
  • Stock Information
  • Founded
  • ATYR 2005
  • KRT 2000
  • Country
  • ATYR United States
  • KRT United States
  • Employees
  • ATYR N/A
  • KRT N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • KRT Plastic Products
  • Sector
  • ATYR Health Care
  • KRT Industrials
  • Exchange
  • ATYR Nasdaq
  • KRT Nasdaq
  • Market Cap
  • ATYR 535.0M
  • KRT 509.2M
  • IPO Year
  • ATYR 2015
  • KRT 2021
  • Fundamental
  • Price
  • ATYR $5.63
  • KRT $24.34
  • Analyst Decision
  • ATYR Strong Buy
  • KRT Buy
  • Analyst Count
  • ATYR 5
  • KRT 4
  • Target Price
  • ATYR $23.25
  • KRT $31.67
  • AVG Volume (30 Days)
  • ATYR 4.3M
  • KRT 70.2K
  • Earning Date
  • ATYR 11-06-2025
  • KRT 11-06-2025
  • Dividend Yield
  • ATYR N/A
  • KRT 7.32%
  • EPS Growth
  • ATYR N/A
  • KRT 12.72
  • EPS
  • ATYR N/A
  • KRT 1.59
  • Revenue
  • ATYR N/A
  • KRT $442,030,000.00
  • Revenue This Year
  • ATYR $478.72
  • KRT $10.75
  • Revenue Next Year
  • ATYR $1,899.26
  • KRT $6.69
  • P/E Ratio
  • ATYR N/A
  • KRT $15.46
  • Revenue Growth
  • ATYR N/A
  • KRT 7.99
  • 52 Week Low
  • ATYR $1.67
  • KRT $23.00
  • 52 Week High
  • ATYR $7.29
  • KRT $33.89
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 58.33
  • KRT 36.42
  • Support Level
  • ATYR $5.08
  • KRT $24.18
  • Resistance Level
  • ATYR $5.77
  • KRT $25.88
  • Average True Range (ATR)
  • ATYR 0.42
  • KRT 0.52
  • MACD
  • ATYR 0.02
  • KRT -0.02
  • Stochastic Oscillator
  • ATYR 66.67
  • KRT 1.76

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About KRT Karat Packaging Inc.

Karat Packaging Inc is engaged in the manufacturing and distribution of disposable products used in restaurants and food service settings. The company operates and evaluates its business as a single reportable segment which encompasses the manufacturing and distribution of a diverse range of single-use food and beverage service products made from materials such as plastic, paper, biopolymer-based, and other compostable forms. The company offers products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery, and straws. These products are available in plastic, paper, biopolymer-based and other compostable forms. Its product line includes a variety of brands such as Tea Zone, Karat, Karat Earth, and Total Clean.

Share on Social Networks: